Vitae Pharmaceuticals LLC
(NASDAQ : VTAE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.01%171.100.7%$969.16m
ABBVAbbVie, Inc. 1.26%139.781.9%$838.43m
PFEPfizer Inc. 0.35%49.440.9%$827.94m
LLYEli Lilly & Co. -0.09%301.041.1%$745.50m
MRKMerck & Co., Inc. 0.28%87.650.7%$741.92m
BMYBristol-Myers Squibb Co. 1.01%72.851.0%$656.40m
SIGASIGA Technologies, Inc. -1.82%22.880.0%$405.41m
AZNAstraZeneca Plc -0.55%65.671.0%$379.39m
ALNYAlnylam Pharmaceuticals, Inc. 5.31%230.198.1%$254.08m
GSKGSK Plc -0.12%40.520.3%$217.59m
HZNPHorizon Therapeutics Plc 0.82%70.175.4%$199.41m
SGENSeagen Inc. 1.97%179.285.7%$192.47m
NVSNovartis AG 0.85%86.300.2%$174.86m
RGENRepligen Corp. 1.96%251.106.7%$158.81m
NVONovo Nordisk A/S 0.19%103.400.1%$153.20m

Company Profile

Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets with significant unmet medical needs, including chronic kidney disease, diabetes, atherosclerosis and Alzheimer's disease.